Bausch Health Cos Current Ratio 2006-2018 | BHC

Current and historical current ratio for Bausch Health Cos (BHC) from 2006 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Bausch Health Cos current ratio for the three months ending September 30, 2018 was 1.14.
Bausch Health Cos Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-09-30 $4.74B $4.16B 1.14
2018-06-30 $4.64B $4.07B 1.14
2018-03-31 $4.72B $3.99B 1.18
2017-12-31 $4.75B $4.27B 1.11
2017-09-30 $5.94B $4.73B 1.26
2017-06-30 $5.99B $4.47B 1.34
2017-03-31 $5.33B $4.25B 1.26
2016-12-31 $5.08B $3.61B 1.41
2016-09-30 $5.67B $3.90B 1.46
2016-06-30 $5.82B $4.23B 1.38
2016-03-31 $6.23B $4.60B 1.36
2015-12-31 $5.51B $5.31B 1.04
2015-09-30 $7.00B $4.65B 1.50
2015-06-30 $6.35B $4.29B 1.48
2015-03-31 $16.19B $3.10B 5.23
2014-12-31 $4.13B $2.71B 1.53
2014-09-30 $4.41B $3.14B 1.40
2014-06-30 $5.16B $2.50B 2.07
2014-03-31 $3.95B $2.56B 1.54
2013-12-31 $3.89B $2.51B 1.55
2013-09-30 $3.85B $2.85B 1.35
2013-06-30 $4.53B $1.76B 2.57
2013-03-31 $2.37B $1.65B 1.44
2012-12-31 $2.78B $1.82B 1.52
2012-09-30 $1.71B $1.16B 1.48
2012-06-30 $1.63B $1.05B 1.55
2012-03-31 $1.53B $0.96B 1.60
2011-12-31 $1.36B $0.92B 1.47
2011-09-30 $1.10B $0.86B 1.27
2011-06-30 $1.05B $0.76B 1.37
2011-03-31 $1.28B $0.66B 1.93
2010-12-31 $1.02B $0.69B 1.47
2010-09-30 $1.30B $0.85B 1.54
2010-06-30 $0.41B $0.23B 1.77
2010-03-31 $0.34B $0.21B 1.63
2009-12-31 $0.34B $0.25B 1.38
2009-09-30 $0.25B $0.22B 1.14
2009-06-30 $0.25B $0.22B 1.13
2009-03-31 $0.47B $0.23B 2.03
2008-12-31 $0.49B $0.27B 1.84
2008-09-30 $0.42B $0.19B 2.21
2008-06-30 $0.66B $0.35B 1.89
2008-03-31 $0.74B $0.39B 1.88
2007-12-31 $0.71B $0.37B 1.92
2007-09-30 $0.62B $0.23B 2.69
2007-06-30 $0.67B $0.28B 2.44
2007-03-31 $1.08B $0.74B 1.46
2006-12-31 $1.06B $0.41B 2.58
2006-09-30 $0.93B $0.27B 3.39
2006-06-30 $0.79B $0.26B 3.09
2006-03-31 $0.72B $0.26B 2.74
2005-12-31 $0.69B $0.27B 2.50
2005-09-30 $0.56B $0.21B 2.70
2005-06-30 $0.46B $0.22B 2.05
2005-03-31 $0.33B $0.19B 1.71
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $8.901B $8.724B
Bausch Health Companies Inc. develops and distributes drugs. It develops drugs for unmet medical needs in central nervous system disorders and distributes generic and branded generic drugs primarily in Latin America and Eastern Europe. Bausch Health Companies Inc., formerly known as Valeant Pharmaceuticals, is based in NJ, United States.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $46.906B 8.33
Teva Pharmaceutical Industries (TEVA) Israel $18.283B 6.31
Mylan (MYL) United Kingdom $16.418B 6.76
Dr Reddy's Laboratories (RDY) India $5.974B 23.83
Supernus Pharmaceuticals (SUPN) United States $2.043B 19.36
Mallinckrodt Public Limited Company (MNK) United Kingdom $1.817B 3.03
Amphastar Pharmaceuticals (AMPH) United States $1.124B 121.90
Homology Medicines (FIXX) United States $0.916B 0.00
CymaBay Therapeutics (CBAY) United States $0.591B 0.00
Assembly Biosciences (ASMB) United States $0.583B 0.00
Akorn (AKRX) United States $0.557B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.414B 0.00
Voyager Therapeutics (VYGR) United States $0.349B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.288B 0.00
Sol-Gel Technologies (SLGL) Israel $0.127B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.092B 0.00
Teligent (TLGT) United States $0.087B 0.00
Acasti Pharma (ACST) Canada $0.071B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.063B 0.00
Evoke Pharma (EVOK) United States $0.053B 0.00
Agile Therapeutics (AGRX) United States $0.037B 0.00
Pernix Therapeutics Holdings (PTX) United States $0.017B 0.00
Aevi Genomic Medicine (GNMX) United States $0.015B 0.00